drugset / Trial / NCT04776486
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
NaSingle-groupOpen-labelDiagnostic
Summary
Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance
Timeline
- Start
- 2020-09-03
- Primary completion
- 2026-01-29
- Completion
- 2026-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iohexol | Diagnostic / imaging agent | 5 ml | Intravenous |
Indications
No indication recorded.